Patent US5256137A successfully refreshed from Google Patents.
US5256137A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biphasic power source for use in an iontophoretic drug delivery system
Assignee: Vyteris Inc
•
Filing: 1992-03-10
•
Granted: 1993-10-26
•
Expires: 2012-03-10
Abstract
Abstract A biphasic power source for use in an iontophoretic system, which system includes a transdermal drug delivery device attachable to a patient and having a positive electrode and a negative electrode, includes a constant current source and a voltage limiting circuit. The constant current source has two outputs and provides a constant current on the outputs. The outputs are connected to the positive and negative electrodes of the transdermal drug delivery device. The voltage limiting circuit is connected in parallel with the outputs of the constant current source to limit the voltage across the electrodes to a predetermined voltage. The voltage limiting circuit may be a zener diode.
Inventors
- 👤 Burton H. Sage, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 10:28
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/0404; A61N1/0408; A61N1/0428; A61N1/0432; A61N1/044; A61N1/18; A61N1/32; A61N1/325; A61N1/0448
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
211 words
An iontophoresis system for delivering therapeutic compounds to the skin of an animal, which comprises: a transdermal drug delivery device attachable to the animal and in communication with the skin thereof, the device including a first electrode and a second electrode, and reservoirs for containing an electrolyte and a therapeutic drug in electrical communication with the first and second electrodes; a biphasic power source connected to the first and second electrodes of the drug delivery device, the biphasic power source including means for providing a constant voltage, and means for providing a constant current, the constant current means and constant voltage means being connected to the electrodes of the drug delivery device; means for switching between said constant voltage providing means and said constant current providing means when the skin impedance of the animal is less than a predetermined level; wherein the biphasic power source is in a first mode and supplying a constant voltage to the first and second electrodes when the skin impedance of the animal is at least equal to a predetermined level, and wherein the biphasic power source is in a second mode and supplying a constant current to the first and second electrodes when the skin impedance of the animal is less than the predetermined level.
Claim 2
Dependent Claim
211 words
An iontophoresis system for delivering therapeutic compounds to the skin of an animal, which comprises: a transdermal drug delivery device attachable to the animal and in communication with the skin thereof, the device including a first electrode and a second electrode, and reservoirs for containing an electrolyte and a therapeutic drug in electrical communication with the first and second electrodes; a biphasic power source connected to the first and second electrodes of the drug delivery device, the biphasic power source including means for providing a constant voltage, and means for providing a constant current, the constant current means and constant voltage means being connected to the electrodes of the drug delivery device; means for switching between said constant voltage providing means and said constant current providing means when the skin impedance of the animal is less than a predetermined level; wherein the biphasic power source is in a first mode and supplying a constant voltage to the first and second electrodes when the skin impedance of the animal is at least equal to a predetermined level, and wherein the biphasic power source is in a second mode and supplying a constant current to the first and second electrodes when the skin impedance of the animal is less than the predetermined level.
Claim 3
Dependent Claim
30 words
An iontophoresis system as defined by claim 1, wherein the constant voltage means limits the voltage across the first and second electrodes to between about 3 and about 30 volts.
Claim 4
Dependent Claim
30 words
An iontophoresis system as defined by claim 1, wherein the constant voltage means limits the voltage across the first and second electrodes to between about 6 and about 20 volts.
Claim 5
Dependent Claim
57 words
An iontophoresis system as defined by claim 1, wherein the means for providing a constant voltage includes a zener diode, and the first electrode is a positive electrode and the second electrode is a negative electrode, and wherein the zener diode has an anode connected to the negative electrode and a cathode connected to the positive electrode.
Claim 6
Dependent Claim
27 words
An iontophoresis system as defined by claim 4, wherein the zener diode is selected to have a breakdown voltage of between about 3 and about 30 volts.
Claim 7
Dependent Claim
27 words
An iontophoresis system as defined by claim 4, wherein the zener diode is selected to have a breakdown voltage of between about 6 and about 20 volts.
Claim 8
Independent Claim
75 words
A method for providing power to electrodes of a transdermal drug delivery device attachable to the skin of an animal, the method comprising the steps of: supplying a constant voltage to the electrodes of the transdermal drug delivery device when the skin impedance of the animal is at least equal to a predetermined level; and supplying a constant current to the electrodes when the skin impedance of the animal is less than the predetermined level.
Claim 9
Independent Claim
75 words
A method for providing power to electrodes of a transdermal drug delivery device attachable to the skin of an animal, the method comprising the steps of: supplying a constant voltage to the electrodes of the transdermal drug delivery device when the skin impedance of the animal is at least equal to a predetermined level; and supplying a constant current to the electrodes when the skin impedance of the animal is less than the predetermined level.
References Cited (Backward Citations)
US3991755A
Cited
US4141359A
Cited
US4164226A
Cited
US4211222A
Cited
US4292968A
Cited
USH516H
Cited
US4457748A
Cited
US4456012A
Cited
US4764164A
Cited
US5042975A
Cited
US4725263A
Cited
WO1991001939A1
Cited
US5047007A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-10-25 | 1997-04-26 | 1997-10-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-10-25 | 2001-04-26 | 2001-10-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-10-25 | 2005-04-26 | 2005-10-26 | $7700.00 | Window Closed / Lapsed |